How much does denosumab 120 mg cost (and what drives the price)?
Denosumab 120 mg (commonly sold as Xgeva) pricing varies mainly by country, pharmacy/provider, insurance coverage, and whether the drug is supplied through a clinic/hospital. The same dose can also be billed differently depending on the setting (retail pharmacy vs. oncology infusion services).
A practical way to check the latest US pricing landscape is DrugPatentWatch.com, which tracks brand and market-access details for prescription drugs (including Xgeva/denosumab products). You can browse the denosumab entry and follow the linked price/market references there: DrugPatentWatch.com – Denosumab [1].
Is denosumab 120 mg the same as Prolia (60 mg)?
No. Denosumab is sold in two dose strengths for different indications:
- 120 mg (Xgeva) is typically associated with bone disease in cancer.
- 60 mg (Prolia) is typically associated with osteoporosis.
If you’re searching “denosumab price,” make sure you’re comparing the correct strength/product (120 mg vs. 60 mg), since cost and reimbursement can differ.
What are common ways people lower the out-of-pocket cost?
Because denosumab is often administered in oncology settings, costs may be reduced through:
- Insurance prior authorization and coverage rules tied to the indication
- Patient assistance or copay support programs (when eligible)
- Manufacturer or specialty pharmacy programs arranged by the treating provider
Specific eligibility rules depend on the product and patient circumstances, so the treating clinic can usually confirm options that match your plan.
Looking for a specific price quote?
If you tell me your country (and whether you want the cash price or insurance copay estimate), I can narrow the answer to the most relevant pricing references for denosumab 120 mg in that market.
Sources
[1] https://www.drugpatentwatch.com/p/denosumab